Difference between revisions of "Part:BBa K1932007"
Line 3: | Line 3: | ||
<partinfo>BBa_K1932007 short</partinfo> | <partinfo>BBa_K1932007 short</partinfo> | ||
− | This device is constructed to express the fusion protein, TAT-apoptin and the region of tmp1 is included to increase the secretion quantity of the protein. Among the subparts, | + | This device is constructed to express the fusion protein, TAT-apoptin and the region of tmp1 is included to increase the secretion quantity of the protein. Among the subparts, BBa_K1932000 is added as a promoter to regulate the expression of exogenous protein in Bifidobacterium with. BBa_K1932001 is included into the device to increase the stability of the device in Bifidobacterium. BBa_K1932003 encodes the signal peptide, tmp1, which can direct the export of the protein from Bididobacterium. BBa_K1932004 encodes TAT-apoptin, which acts as the effector protein to kill the cancer cells. |
<!-- Add more about the biology of this part here | <!-- Add more about the biology of this part here |
Revision as of 08:03, 16 October 2016
This device is constructed for the expression of TAT-apoptin fused with tmp1.
This device is constructed to express the fusion protein, TAT-apoptin and the region of tmp1 is included to increase the secretion quantity of the protein. Among the subparts, BBa_K1932000 is added as a promoter to regulate the expression of exogenous protein in Bifidobacterium with. BBa_K1932001 is included into the device to increase the stability of the device in Bifidobacterium. BBa_K1932003 encodes the signal peptide, tmp1, which can direct the export of the protein from Bididobacterium. BBa_K1932004 encodes TAT-apoptin, which acts as the effector protein to kill the cancer cells.
Sequence and Features
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000INCOMPATIBLE WITH RFC[1000]Illegal SapI site found at 1059